Advertisement
Screener

BIOXYTRAN, INC. (BIXT) Proceeds from Notes Payable

2.8 / 5 stars · 68/120 Roast Me

BIOXYTRAN, INC. Proceeds from Notes Payable

BIOXYTRAN, INC. (BIXT) reported Proceeds from Notes Payable of $1.38 million for the 12-month period ending 2022-12-31, per its 10-K/A filed 2025-01-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromNotesPayable · last filed 2025-01-13

  • BIOXYTRAN, INC. proceeds from notes payable for the quarter ending 2022-12-31 was $0.00.
  • BIOXYTRAN, INC. proceeds from notes payable for the quarter ending 2022-09-30 was $0.00.
  • BIOXYTRAN, INC. proceeds from notes payable for the quarter ending 2022-06-30 was $0.00.
  • BIOXYTRAN, INC. proceeds from notes payable for the quarter ending 2022-03-31 was $1.38M.
  • BIOXYTRAN, INC. proceeds from notes payable for fiscal 2022 was $1.38M, a 18.54% increase from fiscal 2021.
  • BIOXYTRAN, INC. proceeds from notes payable for fiscal 2021 was $1.17M, a 341.29% increase from fiscal 2020.
  • BIOXYTRAN, INC. proceeds from notes payable for fiscal 2020 was $264.00K, a 66.76% decline from fiscal 2019.
  • BIOXYTRAN, INC. proceeds from notes payable for fiscal 2019 was $794.25K, a 257.44% increase from fiscal 2018.
Period endProceeds from Notes Payable 3 monthProceeds from Notes Payable 6 monthProceeds from Notes Payable 6 month as first filedProceeds from Notes Payable 9 monthProceeds from Notes Payable 12 month
2022-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-01-13
$0.00
derived: sum of 2 quarters · filed 2025-01-13
$0.00
derived: sum of 3 quarters · filed 2025-01-13
$1.38M
10-K/A · filed 2025-01-13
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$1.38M
10-Q · filed 2022-11-10
$1.38M
derived: sum of 4 quarters · filed 2023-03-31
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$1.38M
10-Q · filed 2022-08-15
$1.38M
derived: sum of 3 quarters · filed 2023-03-31
$1.38M
derived: sum of 4 quarters · filed 2023-03-31
2022-03-31$1.38M
10-Q · filed 2022-05-23
$1.38M
derived: sum of 2 quarters · filed 2023-03-31
$1.38M
derived: sum of 3 quarters · filed 2023-03-31
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$0.00
derived: sum of 2 quarters · filed 2023-03-31
$1.17M
10-K · filed 2023-03-31
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$1.17M
10-Q · filed 2022-11-10
2021-06-30$1.17M
10-Q · filed 2022-08-15
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11
$0.00
derived: sum of 2 quarters · filed 2022-04-11
$0.00
derived: sum of 3 quarters · filed 2022-04-11
$264.00K
10-K · filed 2022-04-11
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17
$0.00
derived: sum of 2 quarters · filed 2021-11-17
$264.00K
10-Q · filed 2021-11-17
$836.00K
derived: sum of 4 quarters · filed 2021-11-17
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$264.00K
10-Q · filed 2021-08-10
$314.00K
10-Q · filed 2020-08-07
$836.00K
derived: sum of 3 quarters · filed 2021-08-10
$836.00K
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$264.00K
10-Q · filed 2021-05-17
$836.00K
derived: sum of 2 quarters · filed 2021-05-17
$836.00K
derived: sum of 3 quarters · filed 2021-05-17
$836.00K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$572.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-09
$572.00K
derived: sum of 2 quarters · filed 2021-04-09
$572.00K
derived: sum of 3 quarters · filed 2021-04-09
$794.25K
10-K · filed 2021-04-09
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
$0.00
derived: sum of 2 quarters · filed 2020-11-13
$222.25K
10-Q · filed 2020-11-13
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$222.25K
10-Q · filed 2020-08-07
2019-03-31$222.25K
10-Q · filed 2020-05-13
2018-12-31$222.21K
10-K · filed 2020-03-18
2015-09-30$7.17K
10-Q · filed 2015-11-12
2015-06-30$7.17K
10-Q · filed 2015-08-19
2013-12-31$91.00K
10-K · filed 2014-04-14